<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>DISEASE CHARACTERISTICS: The FLNB-related disorders include a spectrum of phenotypes ranging from mild (spondylocarpotarsal <z:mp ids='MP_0000566'>synostosis</z:mp> [SCT] syndrome and <z:e sem="disease" ids="C0175778" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Larsen syndrome</z:e>) to severe (<z:e sem="disease" ids="C0265283" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="AOI">atelosteogenesis</z:e> types I [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AOI</z:e>] and III [AOIII], boomerang <z:mpath ids='MPATH_589'>dysplasia</z:mpath>) </plain></SENT>
<SENT sid="1" pm="."><plain>SCT syndrome is characterized by <z:hpo ids='HP_0003498'>disproportionate short stature</z:hpo>, <z:hpo ids='HP_0003305'>block vertebrae</z:hpo>, <z:hpo ids='HP_0002650'>scoliosis</z:hpo> and <z:hpo ids='HP_0003307'>lordosis</z:hpo>, carpal and <z:hpo ids='HP_0008368'>tarsal fusion</z:hpo>, <z:hpo ids='HP_0001762'>club feet</z:hpo>, hearing loss, <z:hpo ids='HP_0006297'>dental enamel hypoplasia</z:hpo>, and mild <z:hpo ids='HP_0001999'>facial dysmorphisms</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0175778" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Larsen syndrome</z:e> is characterized by <z:hpo ids='HP_0001374'>congenital dislocations of the hip</z:hpo>, knee, and elbow; <z:hpo ids='HP_0001762'>club feet</z:hpo> (<z:hpo ids='HP_0001762'>equinovarus</z:hpo> or equinovalgus <z:hpo ids='HP_0001760'>foot deformities</z:hpo>); <z:hpo ids='HP_0002650'>scoliosis</z:hpo> and <z:hpo ids='HP_0002947'>cervical kyphosis</z:hpo>, which can be associated with a <z:hpo ids='HP_0002318'>cervical myelopathy</z:hpo>; short, broad, spatulate distal phalanges; and distinctive craniofacies (<z:hpo ids='HP_0011220'>prominent forehead</z:hpo>, <z:hpo ids='HP_0005280'>depressed nasal bridge</z:hpo>, flattened midface, and <z:hpo ids='HP_0000316'>ocular hypertelorism</z:hpo>) </plain></SENT>
<SENT sid="3" pm="."><plain>Both can have midline <z:hpo ids='HP_0000175'>cleft palate</z:hpo> and <z:hpo ids='HP_0000405'>conductive hearing loss</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>AOIII and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AOI</z:e> are characterized by severe <z:hpo ids='HP_0008873'>short-limbed dwarfism</z:hpo>; <z:hpo ids='HP_0002827'>dislocated hips</z:hpo>, knees, and elbows; and <z:hpo ids='HP_0001762'>club feet</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AOI</z:e> is lethal in the perinatal period </plain></SENT>
<SENT sid="6" pm="."><plain>DIAGNOSIS/TESTING: Diagnosis is based on clinical and radiographic findings and confirmed with FLNB molecular genetic testing </plain></SENT>
<SENT sid="7" pm="."><plain>MANAGEMENT: Treatment of manifestations: <z:hpo ids='HP_0010646'>Cervical spine instability</z:hpo> in asymptomatic infants is successfully managed with posterior <z:e sem="disease" ids="C0003881,C0003090" disease_type="Disease or Syndrome;Acquired Abnormality;Therapeutic or Preventive Procedure" abbrv="">arthrodesis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Function can be stabilized, if not improved, in infants with myelopathic signs by a combination of anterior decompression and circumferential <z:e sem="disease" ids="C0003881,C0003090" disease_type="Disease or Syndrome;Acquired Abnormality;Therapeutic or Preventive Procedure" abbrv="">arthrodesis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0002827'>Hip dislocation</z:hpo> in <z:e sem="disease" ids="C0175778" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Larsen syndrome</z:e> usually requires operative reduction </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0002650'>Scoliosis</z:hpo> and <z:hpo ids='HP_0001762'>club feet</z:hpo> are managed in a routine manner </plain></SENT>
<SENT sid="11" pm="."><plain>When possible, <z:hpo ids='HP_0000175'>cleft palate</z:hpo> and hearing loss are best managed by multidisciplinary teams </plain></SENT>
<SENT sid="12" pm="."><plain>Prevention of secondary complications: Preemptive posterior stabilization of the cervical spine in <z:e sem="disease" ids="C0175778" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Larsen syndrome</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>When using general anesthesia: prior evaluation for evidence of <z:hpo ids='HP_0010646'>cervical spine instability</z:hpo> and minimizing cervical spine extension intraoperatively; rapid induction and recovery when possible to reduce the risk of airway complications from <z:hpo ids='HP_0008755'>laryngotracheomalacia</z:hpo> </plain></SENT>
<SENT sid="14" pm="."><plain>Surveillance: monitoring in infancy for <z:hpo ids='HP_0002827'>hip dislocation</z:hpo> and later in childhood for progressive <z:hpo ids='HP_0002650'>scoliosis</z:hpo> </plain></SENT>
<SENT sid="15" pm="."><plain>GENETIC COUNSELING: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AOI</z:e>, AOIII, boomerang <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and <z:e sem="disease" ids="C0175778" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Larsen syndrome</z:e> are inherited in an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> manner </plain></SENT>
<SENT sid="16" pm="."><plain>The proportion of <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> FLNB-related disorders caused by de novo mutations is unknown, although the vast majority of lethal FLNB-related conditions are caused by de novo events </plain></SENT>
<SENT sid="17" pm="."><plain>In rare instances, a parent with low-level mosaicism transmits the causative mutation to an affected offspring </plain></SENT>
<SENT sid="18" pm="."><plain>Each child of an individual with an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> FLNB-related disorder has a 50% chance of inheriting the mutation </plain></SENT>
<SENT sid="19" pm="."><plain>Prenatal testing for pregnancies at increased risk for <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> FLNB-related disorders is possible if the disease-causing mutation in the family is known </plain></SENT>
<SENT sid="20" pm="."><plain>SCT syndrome is inherited in an <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> manner </plain></SENT>
<SENT sid="21" pm="."><plain>At conception, each sib of an individual with SCT syndrome has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier </plain></SENT>
<SENT sid="22" pm="."><plain>Carrier testing for at-risk family members and prenatal testing for SCT syndrome are possible once the disease-causing mutations have been identified in the family </plain></SENT>
</text></document>